# Graftech International Ltd: overview

EAF · NYSE · CIK 931148 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eaf.md) · [Financials](/companies/eaf/financials.md) · [Filings](/companies/eaf/filings.md) · [Insiders](/companies/eaf/insiders.md)

Latest reported revenue: [$140.2m](/filings/0000931148-26-000087.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 23, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000931148-26-000087).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [134 d](/filings/0000931148-26-000017.md) | [112](/filings/0000931148-26-000051.md) | [132](/filings/0000931148-26-000073.md) | [144](/filings/0000931148-26-000087.md) | [116 d](/filings/0000931148-26-000017.md) | [125](/filings/0000931148-26-000051.md) | [127](/filings/0000931148-26-000073.md) | [140](/filings/0000931148-26-000087.md) |
| Gross margin | % | [(7.8%) d](/filings/0000931148-26-000017.md) | [(1.5%)](/filings/0000931148-26-000051.md) | [0.0%](/filings/0000931148-26-000073.md) | [7.2%](/filings/0000931148-26-000087.md) | [(20.9%) d](/filings/0000931148-26-000017.md) | [(12.0%)](/filings/0000931148-26-000051.md) | [(0.3%)](/filings/0000931148-26-000073.md) | [4.0%](/filings/0000931148-26-000087.md) |
| Operating margin | % | [(18.6%) d](/filings/0000931148-26-000017.md) | [(16.3%)](/filings/0000931148-26-000051.md) | [(11.0%)](/filings/0000931148-26-000073.md) | [(3.6%)](/filings/0000931148-26-000087.md) | [(33.6%) d](/filings/0000931148-26-000017.md) | [(24.5%)](/filings/0000931148-26-000051.md) | [(11.4%)](/filings/0000931148-26-000073.md) | [(16.2%)](/filings/0000931148-26-000087.md) |
| Net margin | % | [(36.9%) d](/filings/0000931148-26-000017.md) | [(35.2%)](/filings/0000931148-26-000087.md) | [(65.9%)](/filings/0000931148-26-000087.md) | [(19.8%)](/filings/0000931148-26-000087.md) | [(55.9%) d](/filings/0000931148-26-000017.md) | [(34.6%)](/filings/0000931148-26-000087.md) | [(31.8%)](/filings/0000931148-26-000087.md) | [(33.4%)](/filings/0000931148-26-000087.md) |
| Diluted EPS | $ per share | not reported | [(1.52)](/filings/0000931148-26-000051.md) | [(3.35)](/filings/0000931148-26-000073.md) | [(1.10)](/filings/0000931148-26-000087.md) | not reported | [(1.66)](/filings/0000931148-26-000051.md) | [(1.54)](/filings/0000931148-26-000073.md) | [(1.76)](/filings/0000931148-26-000087.md) |
| Free cash flow | $m | [(39.2) d](/filings/0000931148-26-000017.md) | [(42.5)](/filings/0000931148-26-000051.md) | [(57.1) d](/filings/0000931148-26-000073.md) | [18.4 d](/filings/0000931148-26-000087.md) | [(39.3) d](/filings/0000931148-26-000017.md) | [(27.1)](/filings/0000931148-26-000051.md) | [(75.5) d](/filings/0000931148-26-000073.md) | [(16.3) d](/filings/0000931148-26-000087.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,346](/filings/0000931148-24-000021.md) | [1,281](/filings/0000931148-25-000028.md) | [621](/filings/0000931148-26-000017.md) | [539](/filings/0000931148-26-000017.md) | [504](/filings/0000931148-26-000017.md) |
| Gross margin | % | [47.9%](/filings/0000931148-24-000021.md) | [43.3%](/filings/0000931148-25-000028.md) | [5.8%](/filings/0000931148-26-000017.md) | [(3.7%)](/filings/0000931148-26-000017.md) | [(3.1%)](/filings/0000931148-26-000017.md) |
| Operating margin | % | [37.8%](/filings/0000931148-24-000021.md) | [37.0%](/filings/0000931148-25-000028.md) | [(34.6%)](/filings/0000931148-26-000017.md) | [(14.0%)](/filings/0000931148-26-000017.md) | [(15.3%)](/filings/0000931148-26-000017.md) |
| Net margin | % | [28.9%](/filings/0000931148-24-000021.md) | [29.9%](/filings/0000931148-25-000028.md) | [(41.1%)](/filings/0000931148-26-000017.md) | [(24.3%)](/filings/0000931148-26-000017.md) | [(43.6%)](/filings/0000931148-26-000017.md) |
| Diluted EPS | $ per share | [1.46](/filings/0000931148-24-000021.md) | [1.48](/filings/0000931148-25-000028.md) | [(9.93)](/filings/0000931148-26-000017.md) | [(5.09)](/filings/0000931148-26-000017.md) | [(8.45)](/filings/0000931148-26-000017.md) |
| Free cash flow | $m | [385](/filings/0000931148-24-000021.md) | [252](/filings/0000931148-25-000028.md) | [22.5](/filings/0000931148-26-000017.md) | [(74.4)](/filings/0000931148-26-000017.md) | [(121)](/filings/0000931148-26-000017.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/eaf/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2024-01-02 | [BCP GP Ltd](/insiders/1685160.md) | Former 10% Owner | Sale (S) | 68 | $2.20 | $149.60 | [Form 4](/filings/0001140361-24-000782.md) |
| 2024-01-02 | [BCP GP Ltd](/insiders/1685160.md) | Former 10% Owner | Sale (S) | 88 | $2.20 | $193.60 | [Form 4](/filings/0001140361-24-000782.md) |
| 2024-01-02 | [BCP GP Ltd](/insiders/1685160.md) | Former 10% Owner | Sale (S) | 1,846,591 | $2.20 | $4.1m | [Form 4](/filings/0001140361-24-000782.md) |
| 2024-01-02 | [BCP GP Ltd](/insiders/1685160.md) | Former 10% Owner | Sale (S) | 1,038,919 | $2.20 | $2.3m | [Form 4](/filings/0001140361-24-000782.md) |
| 2024-01-02 | [BCP GP Ltd](/insiders/1685160.md) | Former 10% Owner | Sale (S) | 1,037,120 | $2.20 | $2.3m | [Form 4](/filings/0001140361-24-000782.md) |
| 2023-12-29 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 2 | $2.2164 | $4.43 | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-29 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 3 | $2.2164 | $6.65 | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-29 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 60,735 | $2.2164 | $134.6k | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-29 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 34,171 | $2.2164 | $75.7k | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-29 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 34,111 | $2.2164 | $75.6k | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-28 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 7 | $2.2323 | $15.63 | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-28 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 9 | $2.2323 | $20.09 | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-28 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 180,142 | $2.2323 | $402.1k | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-28 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 101,350 | $2.2323 | $226.2k | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-28 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 101,174 | $2.2323 | $225.9k | [Form 4](/filings/0001140361-23-060299.md) |
| 2023-12-27 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 7 | $2.1155 | $14.81 | [Form 4](/filings/0001140361-23-059659.md) |
| 2023-12-27 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 9 | $2.1155 | $19.04 | [Form 4](/filings/0001140361-23-059659.md) |
| 2023-12-27 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 197,390 | $2.1155 | $417.6k | [Form 4](/filings/0001140361-23-059659.md) |
| 2023-12-27 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 111,055 | $2.1155 | $234.9k | [Form 4](/filings/0001140361-23-059659.md) |
| 2023-12-27 | [BCP GP Ltd](/insiders/1685160.md) | 10% owner | Sale (S) | 110,863 | $2.1155 | $234.5k | [Form 4](/filings/0001140361-23-059659.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $7.6m | 1,284,282 |  | Added +953,457 |
| [YACKTMAN ASSET MANAGEMENT LP](/funds/905567.md) | 2026-06-30 | $6.8m | 1,149,267 |  | Added +81,881 |
| [MARATHON ASSET MANAGEMENT LP](/funds/1279913.md) | 2026-06-30 | $5.7m | 962,828 |  | Reduced −248,787 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.8m | 816,833 |  | Reduced −47,773 |
| [Benefit Street Partners LLC](/funds/1543160.md) | 2026-06-30 | $4.4m | 736,745 |  | Added +23,683 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $4.4m | 736,745 |  | Added +23,683 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $4.3m | 720,361 |  | Added +157,861 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $3.3m | 563,633 |  | Reduced −348,329 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $2.6m | 446,482 |  | Reduced −282,136 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.5m | 425,244 |  | Added +254,737 |

## Recent filings

[All 1,418 filings](/companies/eaf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:42 ET | [8-K/A](/filings/0000931148-26-000090.md) | 2.05 Exit or disposal costs | 0000931148-26-000090 |
| 2026-10-23 | 11:58 ET | [10-Q](/filings/0000931148-26-000087.md) | Quarterly report, period 2026-09-30 | 0000931148-26-000087 |
| 2026-10-23 | 06:42 ET | [8-K](/filings/0000931148-26-000085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000931148-26-000085 |
| 2026-09-18 | 16:45 ET | [SCHEDULE 13D/A](/filings/0001944761-26-000004.md) | Ownership report, active investor, amended | 0001944761-26-000004 |
| 2026-08-31 | 17:15 ET | [8-K](/filings/0000931148-26-000075.md) | 2.05 Exit or disposal costs | 0000931148-26-000075 |
| 2026-07-24 | 12:25 ET | [10-Q](/filings/0000931148-26-000073.md) | Quarterly report, period 2026-06-30 | 0000931148-26-000073 |
| 2026-07-24 | 06:49 ET | [8-K](/filings/0000931148-26-000071.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000931148-26-000071 |
| 2026-05-29 | 17:26 ET | [8-K](/filings/0001193125-26-248897.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-248897 |
| 2026-05-08 | 16:20 ET | [8-K](/filings/0000931148-26-000053.md) | 5.07 Shareholder vote results | 0000931148-26-000053 |
| 2026-05-01 | 12:21 ET | [10-Q](/filings/0000931148-26-000051.md) | Quarterly report, period 2026-03-31 | 0000931148-26-000051 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000931148-26-000017.md), filed Feb 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 931148
- Tickers: EAF
- Exchange: NYSE
- SIC code: 3620 Electrical Industrial Apparatus
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:43 ET. No prices; not investment advice.